Surgery Dynamics, Inc. announces the signing of a three-year national agreement with Premier Purchasing Partners, the group purchasing unit of Premier, Inc. for protective eyewear. The Premier agreement for these eyeshields is available to the surgical staff to the more than 2,400 U.S. hospitals and 70,000 healthcare sites that are members of the Premier healthcare alliance. The agreement (PP-OR-709), which takes effect Jan. 1, 2011, includes Biobans eyeshields.
"We are very excited to have been chosen by Premier for this contract award. This agreement will allow the Premier member hospitals and healthcare facilities to immediately benefit from our superior eyeshield design," says Elaine Rogers, president of Surgery Dynamics. "Our innovative eyewear gives Premier members an efficient and cost-effective way to comply with recommended standards of practice for eye protection and offer the best available option for their healthcare workers."
Surgery Dynamics says Biobans are an ideal source for eye protection because of their unique design. The protective lens has 27 percent more surface area coverage than the other available eyeshield designs. This added protection means additional defense against splashing and spraying by potentially infectious material.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.